[New developments and perspectives in outpatient general internal medicine]. / Nouveautés et perspectives en médecine interne générale ambulatoire.

Several studies have been published in 2023, in the field of general internal medicine, addressing various aspects of health and covering topics ranging from hormonal treatment of menopause to the management of chronic and acute diseases. A selection of articles was chosen for this update in outpatient general internal medicine, showing recent studies on outpatient care of patients (treatment, follow-up). The summary of articles is supplemented this year by a table of medical recommendations published in 2023, modestly proposed, and covering various areas. These guidelines, most of them from North America, show advances in the care and monitoring of outpatients, and should be interpreted in light of the various recommendations in Switzerland.

En 2023, plusieurs études ont été publiées dans le champ de la médecine interne générale, abordant divers aspects de la santé et couvrant des sujets allant du traitement hormonal de la ménopause à la gestion de maladies chroniques et aiguës. Un bouquet d'articles a été choisi pour cette mise à jour en médecine interne générale ambulatoire, traitant d'études récentes sur la prise en charge en ambulatoire (traitement, suivi) des patientes et patients. Le résumé d'articles est complété d'un tableau de nouvelles recommandations médicales de 2023, humblement proposé, couvrant divers domaines. Ces guidelines, pour la plupart américaines, montrent les avancées dans la prise en charge et le suivi des patientes et patients en ambulatoire, et sont à interpréter à la lumière des différentes recommandations en Suisse.

[Primary care physicians and community pharmacists: a tandem collaboration that should be strengthened and (re)focused on the patient?]. / Médecins de premier recours et pharmaciens d'officine: un tandem amené a se renforcer et a se (re)centrer sur le patient?

In addition to the well-established interdisciplinary relationship of doctors and pharmacists when dealing with specific patients, new and more structured forms of interaction are emerging aimed at improving the overall quality and efficiency of patient care. We explore the challenges of a productive patient-centered collaboration between these two health care professions and describe three examples from french speaking part of Switzerland which demonstrate how primary care physicians and pharmacists can effectively collaborate on more than one level to the patient's benefit. Special attention will be given to the role of pharmacists at the heart of integrated health systems, which are about to be implemented in Switzerland. We further discuss current evidence on the role of community pharmacists in the management of cardiovascular risk factors and the coordination of treatment for chronic disease.